JP2015504860A5 - - Google Patents

Download PDF

Info

Publication number
JP2015504860A5
JP2015504860A5 JP2014546154A JP2014546154A JP2015504860A5 JP 2015504860 A5 JP2015504860 A5 JP 2015504860A5 JP 2014546154 A JP2014546154 A JP 2014546154A JP 2014546154 A JP2014546154 A JP 2014546154A JP 2015504860 A5 JP2015504860 A5 JP 2015504860A5
Authority
JP
Japan
Prior art keywords
composition
emulsion
castor oil
dry eye
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014546154A
Other languages
English (en)
Other versions
JP6142419B2 (ja
JP2015504860A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/068615 external-priority patent/WO2013086449A1/en
Publication of JP2015504860A publication Critical patent/JP2015504860A/ja
Publication of JP2015504860A5 publication Critical patent/JP2015504860A5/ja
Application granted granted Critical
Publication of JP6142419B2 publication Critical patent/JP6142419B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (18)

  1. 人工涙液として有用な組成物であって、ヒマシ油を含む無塩エマルジョンであり、具体的にオリーブ油を除外し、かつポリソルベート、カルボキシメチルセルロース、およびグリセリンからなる群から選択される少なくとも1つの活性薬剤を含有する、組成物。
  2. 前記混合物は、0.1重量/重量%〜0.5重量/重量%のヒマシ油を含む、請求項1に記載の組成物。
  3. ヒマシ油は、前記エマルジョン中の唯一の油である、請求項2に記載の組成物。
  4. 前記ヒマシ油は、水相中乳化されている、請求項3に記載の組成物。
  5. 前記ヒマシ油は、約0.25重量/重量%で存在する、請求項4に記載の組成物。
  6. 第1の乳化剤および第2の乳化剤を更に含む、請求項5に記載の組成物。
  7. 前記組成物は、防腐剤を含有する、請求項5に記載の組成物。
  8. 前記防腐剤は、PURITEおよび塩化ベンザルコニウム(benzalkoniuim chloride)からなる群から選択される、請求項7に記載の組成物。
  9. 前記防腐剤は、Purite(登録商標)であり、約0.01重量/体積%の濃度で存在する、請求項8に記載の組成物。
  10. ドライアイの治療における使用のためのエマルジョンであって、無塩であり、かつヒマシ油、ポリソルベート80、カルボキシメチルセルロース、およびグリセリンを含む、エマルジョン。
  11. 前記エマルジョンは、乳化剤ペムリン(pemulin)も含有する、請求項10に記載の組成物。
  12. エリトリトールおよびレボカルニチンを更に含む、請求項11に記載のエマルジョン。
  13. 表1に示すような、ドライアイを治療するためのエマルジョン。
  14. 表1に示すような組成物のいずれかを含む、ドライアイを治療するための医薬組成物
  15. 前記表1に示すような組成物は、防腐剤を含まない、請求項14に記載の医薬組成物
  16. 少なくとも1日1回適用されるように用いられる、請求項14に記載の医薬組成物
  17. 前記表1に示すような組成物は、ドライアイ症候群の兆候を緩和する、請求項15に記載の医薬組成物
  18. 前記表1に示すような組成物は、ドライアイ症候群を治療および予防する、請求項15に記載の医薬組成物
JP2014546154A 2011-12-07 2012-12-07 塩感受性エマルジョン系を用いたヒト涙液膜への効率的脂質送達 Active JP6142419B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161568089P 2011-12-07 2011-12-07
US61/568,089 2011-12-07
US201261625401P 2012-04-17 2012-04-17
US61/625,401 2012-04-17
PCT/US2012/068615 WO2013086449A1 (en) 2011-12-07 2012-12-07 Efficient lipid delivery to human tear film using a salt-sensitive emulsion system

Publications (3)

Publication Number Publication Date
JP2015504860A JP2015504860A (ja) 2015-02-16
JP2015504860A5 true JP2015504860A5 (ja) 2016-02-04
JP6142419B2 JP6142419B2 (ja) 2017-06-07

Family

ID=47459152

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014546154A Active JP6142419B2 (ja) 2011-12-07 2012-12-07 塩感受性エマルジョン系を用いたヒト涙液膜への効率的脂質送達

Country Status (28)

Country Link
US (2) US20130150324A1 (ja)
EP (5) EP4403220A3 (ja)
JP (1) JP6142419B2 (ja)
KR (1) KR102017922B1 (ja)
CN (2) CN104114152A (ja)
AR (1) AR089123A1 (ja)
AU (2) AU2012347459A1 (ja)
BR (1) BR112014013820A8 (ja)
CA (1) CA2858574C (ja)
CL (1) CL2014001518A1 (ja)
CO (1) CO6990739A2 (ja)
DK (2) DK2787969T3 (ja)
ES (2) ES2797650T3 (ja)
HK (2) HK1201458A1 (ja)
HU (2) HUE057140T2 (ja)
IL (1) IL233008A (ja)
IN (1) IN2014CN04809A (ja)
MX (1) MX355216B (ja)
MY (1) MY173378A (ja)
PH (1) PH12014501296A1 (ja)
PL (2) PL2787969T3 (ja)
PT (2) PT2787969T (ja)
RU (1) RU2014127074A (ja)
SG (1) SG11201403013VA (ja)
SI (2) SI2787968T1 (ja)
TW (1) TWI652072B (ja)
WO (2) WO2013086449A1 (ja)
ZA (1) ZA201404228B (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8957048B2 (en) * 2011-10-06 2015-02-17 Allergan, Inc. Compositions for the treatment of dry eye
US9907826B2 (en) 2011-12-07 2018-03-06 Allergan, Inc. Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
JOP20170147B1 (ar) 2016-07-07 2021-08-17 Salvat Lab Sa تركيبة عينية تشتمل على زيت الخروع ودهون ثلاثية متوسطة السلسلة
WO2018035469A1 (en) 2016-08-19 2018-02-22 Akrivista, LLC Methods of diagnosing and treating dry eye syndrome and compositions for treating a human eye
JP7311160B2 (ja) 2017-08-18 2023-07-19 アクリビスタ エルエルシー ドライアイ症候群を診断及び処置する方法及びヒトの眼を処置するための組成物
CN112272578A (zh) 2018-04-27 2021-01-26 阿勒根公司 抗微生物功效增强且毒性降低的亚氯酸钠组合物

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4201706A (en) 1978-09-22 1980-05-06 Burton, Parsons & Company, Inc. Treatment of corneal edema
ATE6466T1 (de) 1979-10-26 1984-03-15 Smith And Nephew Associated Companies P.L.C. Autoklavierbare emulsionen.
US5192535A (en) 1988-02-08 1993-03-09 Insite Vision Incorporated Ophthalmic suspensions
IT1224795B (it) 1988-12-01 1990-10-24 Sigma Tau Ind Farmaceuti Uso dell'acetil d-carnitina nel trattamento terapeutico del glaucoma e composizioni farmaceutiche utili in tale trattamento
DE436726T1 (de) 1989-08-03 1992-02-06 Eisai Co., Ltd., Tokio/Tokyo Verfahren zur photostabilisierung von augenspuelloesungen sowie photostabilisierte augenspuelloesung.
US5681555A (en) 1991-04-22 1997-10-28 Gleich; Gerald J. Method for the treatment of bronchial asthma by parenteral administration of anionic polymers
DE4229494A1 (de) 1992-09-04 1994-03-10 Basotherm Gmbh Arzneimittel zur topischen Anwendung am Auge zur Behandlung des erhöhten intraokularen Drucks
CA2199610A1 (en) 1994-09-14 1996-03-21 Taisho Pharmaceutical Co., Ltd. Eye drops for repairing repairing corneal damage
US5980865A (en) 1995-08-18 1999-11-09 Baker Norton Pharmaceuticals, Inc. Method for treating late phase allergic reactions and inflammatory diseases
FI106923B (fi) 1997-01-03 2001-05-15 Cultor Ltd Finnsugar Bioproduc Trimetyyliglysiinin käyttö kehon limakalvojen hygieniaan ja hoitoon tarkoitetuissa valmisteissa
AR002194A1 (es) 1997-03-17 1998-01-07 Sanchez Reynaldo Alemany Instrumento computarizado para el analisis del movimiento.
IT1302307B1 (it) 1998-09-01 2000-09-05 Sigma Tau Healthscience Spa Composizione ad attivita' antiossidante ed atta a migliorarel'utilizzazione metabolica del glucosio, comprendente acetil
DE69919379T2 (de) 1998-11-13 2005-09-08 Continental Projects Ltd. Komplexe von hyaluronic saure/carnitinen und pharmazeutische und kosmetische zusammensetzungen
JP2000159659A (ja) 1998-11-30 2000-06-13 Kazuo Tsubota 眼科用人工涙液
US6228392B1 (en) 1999-04-29 2001-05-08 Gene Tools, Llc Osmotic delivery composition, solution, and method
DK2153819T3 (da) 2000-07-14 2012-12-03 Allergan Inc Anvendelse af en opløselighedsforbedrende bestanddel i en vandig sammensætning omfattende brimonidintartrat
AU781975B2 (en) 2000-09-14 2005-06-23 Hayashibara Co., Ltd Pharmaceutical composition for ophthalmic use
CA2428985C (en) 2000-11-08 2011-05-24 Bio-Concept Laboratories Improved ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers
US7045121B2 (en) 2001-12-14 2006-05-16 Allergan, Inc. Ophthalmic compositions for lubricating eyes and methods for making and using same
JP2006504701A (ja) 2002-09-30 2006-02-09 マーク・エー・バビザイェフ 眼疾患の局所的治療方法、並びに、その治療用組成物及び治療用手段
US7758883B2 (en) * 2002-10-18 2010-07-20 Aqueous Pharma Limited Three layer artificial tear formulation
US20040137079A1 (en) 2003-01-08 2004-07-15 Cook James N. Contact lens and eye drop rewetter compositions and methods
US6635654B1 (en) * 2003-01-09 2003-10-21 Allergan, Inc. Ophthalmic compositions containing loratadine
JPWO2004084877A1 (ja) 2003-03-26 2006-06-29 株式会社メニコン 眼科用組成物
KR101147046B1 (ko) * 2003-06-13 2012-05-22 알콘, 인코퍼레이티드 시너지성의 2개의 폴리머 배합물을 포함하는 안과용 조성물
TWI336257B (en) * 2003-06-13 2011-01-21 Alcon Inc Ophthalmic compositions containing a synergistic combination of three polymers
US20050009836A1 (en) 2003-06-26 2005-01-13 Laskar Paul A. Ophthalmic composition containing quinolones and method of use
EP1683528A4 (en) * 2003-11-10 2011-07-27 Toray Industries POLYSACCHARIDE-CONTAINING COMPOSITION AND OPHTHALMIC SOLUTION FOR STABILIZING THE TISSUE FILM
US8569367B2 (en) 2004-11-16 2013-10-29 Allergan, Inc. Ophthalmic compositions and methods for treating eyes
US7288520B2 (en) * 2005-07-13 2007-10-30 Allergan, Inc. Cyclosporin compositions
US9561178B2 (en) * 2006-07-25 2017-02-07 Allergan, Inc. Cyclosporin compositions
WO2008035246A2 (en) * 2006-07-28 2008-03-27 Novagali Pharma Sa Compositions containing quaternary ammonium compounds
CN101896160A (zh) * 2006-10-17 2010-11-24 阿勒根公司 环胞菌素组合物
BRPI0808410A2 (pt) 2007-02-28 2015-06-23 Aciex Therapeutics Inc Métodos e composições para normalizar secreções da glândula meibomiana
JP4929245B2 (ja) 2008-07-31 2012-05-09 株式会社ベッセル工業 工具類のグリップ
WO2010141648A2 (en) * 2009-06-05 2010-12-09 Allergan, Inc. Artificial tears and therapeutic uses
US8957048B2 (en) * 2011-10-06 2015-02-17 Allergan, Inc. Compositions for the treatment of dry eye

Similar Documents

Publication Publication Date Title
JP2015504860A5 (ja)
MX2020012595A (es) Composiciones farmaceuticas topicas.
SI2437762T1 (en) Artificial tears and therapeutic use
PH12015502587B1 (en) Ophthalmic nanoemulsion composition containing cyclosporine and method for preparing same
EP4374851A3 (en) Ophthalmic composition for treatment of dry eye disease
BR112015019657A2 (pt) composições tópicas e métodos de uso das mesmas
TR201904455T4 (tr) Nükleer taşıma modülatörleri olarak 1,2,4-triazoller ve bunların kullanımları.
JP2018526325A5 (ja)
EA201291108A1 (ru) Фармацевтические композиции в виде эмульсии с низким содержанием масла, содержащие прогестоген
BR112014010275A2 (pt) formulações para tratamento de diabetes
MY180145A (en) Cenicriviroc compositions and methods of making and using the same
BR112015001847A8 (pt) Composições e tratamento para doenças e distúrbios nos olhos
NZ629045A (en) Topical compositions comprising fipronil and permethrin and methods of use
RU2016135039A (ru) Композиция для обработки поверхностных дефектов
EA201691490A1 (ru) Фармацевтическая композиция, содержащая бринзоламид
RU2014127074A (ru) Состав для эффективной доставки липидов в слезную пленку человека с использованием чувствительной к соли эмульсионной системы
RU2014148544A (ru) Составы на основе полиинозиновой-полицитидиловой кислоты (poly(i:с)) для лечения инфекций верхних дыхательных путей
RU2019139886A (ru) Терапевтическое средство против дисфункции мейбомиевых желез
JP2016502979A5 (ja)
BR112015001627A2 (pt) composição farmacêutica, respectivos usos e método para diminuir a frequência de micção
BR112017014016A2 (pt) método de redução da pressão intraocular, e, composição farmacêutica.
GEP201706644B (en) Insecticidal water-in-oil (w/o) formulation
FI3373976T3 (fi) Topikaalisia formulaatioita ja niiden käyttöjä
EA201200754A1 (ru) Традиционное китайское лекарственное средство, содержащее экстракты дан-шен (danshen) и сан-ки (sanqi), и его применение
JP2016175884A5 (ja)